Factor | Kim2005a (20004)

Treatment

Swine | Sows

Treatment group was the use of Porcine-derived mucosal competitive exclusion vs. control. Apramycin use was 32 micrograms/mL

Resistance

Microbe

Outcome

Apramycin
/

Escherichia coli

See: Table 2	AMR+ (%)	AMR- (%)	Total (n)
Treatment	0.00		249
Control	0.50		250